Current Research: I am a Neuroscience graduate student and a graduate student researcher in the Kolber Lab, currently studying the lateralization of neuropeptide pathways in the amygdala and their subsequent roles in modulating both chronic pain and comorbid mental illnesses.
Research Interests: My further research interests include the neurobiology of memory processing, psychedelic studies, and translational interventions through leveraging neuroplasticity mechanisms.
Study: Identifying with Symptoms in COVID-19
Abstract: This study examined the effects of using primers that normalize and contextualize depressive symptoms within the setting of the COVID-19 pandemic on subsequent rates of reporting experiencing depressive symptoms, relative to responses to questions lacking such primers. Data, collected through surveys using a within-subjects design where all participants were exposed to both conditions, was used from 126 participants from the University of Texas at Dallas. Results showed that when responding to questions using primed language that included prompts normalizing and contextualizing depressive symptoms within the COVID-19 pandemic (experimental group), participants reported experiencing depressive symptoms at a similar rate to when participants responded to questions about depressive symptoms that lacked such prompts (control group). Ultimately, there were no notable differences between the two groups. Theoretical and practical implications were discussed.
Principal Investigators: Uma Chatterjee, Stephanie Hammett, & Rebecca Nichols
Literature Review: The Power of Psilocybin-Assisted Therapy
Research Question: This literature review will be exploring the question of if psilocybin-assisted therapy for mental health conditions currently treated by antidepressants has a higher efficacy rate than antidepressants; and if so, what the mechanisms are of psilocybin that result in its differentiated success.
Author: Uma Chatterjee